Annual Recurring Revenue guidance for 2026
Company: Nebius
The claim, verbatim
ARR guidance of $7B to $9B by year-end 2026
Source (primary)
Should You Grab Nebius In Anticipation of Full Capacity Pricing? - 24/7 Wall St. (-, news_article)
View cached copy (2026-09-11)Live source ↗Archive.org ↗
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Should You Grab Nebius In Anticipation of Full Capacity Pricing? - 24/7 Wall St.
Quote: “ARR guidance of $7B to $9B by year-end 2026 was reaffirmed”